In conclusion, both the increase of Adiponectin and Orexin-A concentrations corresponds to the improvement of wellness and may be a new potential therapeutic method for controlling obesity by regulating physical activity and energy expenditure. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.